Molecular characterisation of second-line drug resistance among drug resistant tuberculosis patients tested in Uganda: a two and a half-year’s review

BACKGROUND: Second-line drug resistance (SLD) among tuberculosis (TB) patients is a serious emerging challenge towards global control of the disease. We characterized SLD-resistance conferring-mutations among TB patients with rifampicin and/or isoniazid (RIF and/or INH) drug-resistance tested at the...

Descripción completa

Detalles Bibliográficos
Autores principales: Mujuni, Dennis, Kasemire, Dianah Linda, Ibanda, Ivan, Kabugo, Joel, Nsawotebba, Andrew, Phelan, Jody E., Majwala, Robert Kaos, Tugumisirize, Didas, Nyombi, Abdunoor, Orena, Beatrice, Turyahabwe, Irene, Byabajungu, Henry, Nadunga, Diana, Musisi, Kenneth, Joloba, Moses Lutakoome, Ssengooba, Willy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9003953/
https://www.ncbi.nlm.nih.gov/pubmed/35410160
http://dx.doi.org/10.1186/s12879-022-07339-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9003953/
https://www.ncbi.nlm.nih.gov/pubmed/35410160
http://dx.doi.org/10.1186/s12879-022-07339-w

Ejemplares similares